netFormulary

Lancashire and South Cumbria
Formulary

12 Ear, nose and oropharynx

Several medicines in the ear, nose and oropharynx chapter are available for purchase over the counter and may be appropriate for self care. Please consult the local OTC policy for more details

12-01-01 Anti-inflammatory preparations

Betamethasone Betnesol^®

Formulary

Ear/eye/nose drops betamethasone 0.1%

Betamethasone with neomycin Betnesol N^®

Formulary

Ear/eye/nose drops betamethasone 0.1% with Neomycin 0.5%

For use in nasal infection see section 12.02.03.

MHRA: Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations

Dexamethasone with framycetin sulfate and gramicidin Sofradex^®

Formulary

Ear/eye drops dexamethasone (as sodium metasulphobenzoate) 0.05%, framycetin sulfate 0.5%, gramicidin 0.005%

Sofradex® is less suitable for prescribing.

MHRA: Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations

Dexamethasone with glacial acetic acid and neomycin sulfate

Formulary

Ear spray acetic acid glacial 2%, Dexamethasone 0.1%, Neomycin sulfate 0.5%

MHRA: Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations

Flumetasone pivalate with clioquinol

Formulary

Ear drops flumetasone 0.02% with clioquinol 1%

Gentamicin with hydrocortisone

Formulary

Ear drops hydrocortisone acetate 1% with gentamicin 0.3%

Medicines for children: Gentamicin and hydrocortisone ear drops for inflammatory ear infections

MHRA: Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations

Links